Myelin Imaging of the Spinal Cord in Animal Models and Patients with Multiple Sclerosis Using [C]MeDAS PET: A Translational Study

Overview

Journal J Nucl Med

Specialty Nuclear Medicine

Date 2024 Dec 5

PMID 39638431

Authors

Chris W J van der Weijden

Ahmed K M A Ahmed

Anouk van der Hoorn

Junqing Zhu

Chunying Wu

Yanming Wang

Gilles N Stormezand

Rudi A J O Dierckx

Jan F Meilof

Erik F J de Vries

Affiliations

Soon will be listed here.

Abstract

Multiple sclerosis (MS) is a neurodegenerative disease characterized by demyelinated lesions in the brain and spinal cord. A few clinical studies using PET to image myelin in the brain have been performed, but none investigated the spinal cord. Because clinically relevant motor symptoms are primarily due to spinal cord damage, this translational study evaluated [C]-methyl-4,4'-diaminostilbene (MeDAS) as a PET tracer for myelin imaging in the rat and human spinal cord. [C]MeDAS PET of the spinal cord was conducted in experimental autoimmune encephalomyelitis, lysophosphatidylcholine, and spinal cord injury animal models of focal demyelination. Then, 6 healthy controls and 11 MS patients were subjected to MRI and [C]MeDAS PET of the spinal cord between C5 and T6 vertebrae. Regions of interest covering 100%, 60%, and 40% of the diameter of the spinal canal were drawn, and tracer uptake was normalized to the activity in the blood pool, muscle, or injected dose per unit of body weight (SUV). [C]MeDAS uptake was significantly reduced in spinal cord lesions in all animal models. In humans, tracer uptake was significantly higher in the cervical than the thoracic spinal cord, which corresponds well with the known physiologic rostral-caudal gradient in myelin density. MS patients had significantly lower [C]MeDAS uptake in the upper spinal cord (C5-T3) than did controls. The [C]MeDAS PET signal was inversely correlated with the presence of MS lesions in specific sections of the spinal cord. The best differentiation among regions with different myelin density was obtained when the smallest region of interest was used and spinal cord uptake was expressed as SUV. [C]MeDAS PET shows the potential to quantify myelin density in the spinal cord. It enables detection of physiologic differences in myelin density between spinal cord segments and between MS patients and healthy controls, which warrants further evaluation of this technique.

References

Moccia M, Ruggieri S, Ianniello A, Toosy A, Pozzilli C, Ciccarelli O . Advances in spinal cord imaging in multiple sclerosis. Ther Adv Neurol Disord. 2019; 12:1756286419840593. PMC: 6477770. DOI: 10.1177/1756286419840593. View

Wu C, Zhu J, Baeslack J, Zaremba A, Hecker J, Kraso J . Longitudinal positron emission tomography imaging for monitoring myelin repair in the spinal cord. Ann Neurol. 2013; 74(5):688-98. DOI: 10.1002/ana.23965. View

Wu C, Wang C, Popescu D, Zhu W, Somoza E, Zhu J . A novel PET marker for in vivo quantification of myelination. Bioorg Med Chem. 2010; 18(24):8592-9. PMC: 3044472. DOI: 10.1016/j.bmc.2010.10.018. View

van der Weijden C, Meilof J, van der Hoorn A, Zhu J, Wu C, Wang Y . Quantitative assessment of myelin density using [C]MeDAS PET in patients with multiple sclerosis: a first-in-human study. Eur J Nucl Med Mol Imaging. 2022; 49(10):3492-3507. PMC: 9308583. DOI: 10.1007/s00259-022-05770-4. View

Schoenen J . Clinical anatomy of the spinal cord. Neurol Clin. 1991; 9(3):503-32. View

Huang S . Anatomy of SUV. Standardized uptake value. Nucl Med Biol. 2000; 27(7):643-6. DOI: 10.1016/s0969-8051(00)00155-4. View

Lycklama A Nijeholt G, Barkhof F, Scheltens P, Castelijns J, Ader H, van Waesberghe J . MR of the spinal cord in multiple sclerosis: relation to clinical subtype and disability. AJNR Am J Neuroradiol. 1997; 18(6):1041-8. PMC: 8337294. View

Laffon E, Cazeau A, Monet A, de Clermont H, Fernandez P, Marthan R . The effect of renal failure on 18F-FDG uptake: a theoretic assessment. J Nucl Med Technol. 2008; 36(4):200-2. DOI: 10.2967/jnmt.107.049627. View

Bodini B, Veronese M, Garcia-Lorenzo D, Battaglini M, Poirion E, Chardain A . Dynamic Imaging of Individual Remyelination Profiles in Multiple Sclerosis. Ann Neurol. 2016; 79(5):726-738. PMC: 5006855. DOI: 10.1002/ana.24620. View

10.

Keyes Jr J . SUV: standard uptake or silly useless value?. J Nucl Med. 1995; 36(10):1836-9. View

11.

Traugott U, Reinherz E, Raine C . Multiple sclerosis. Distribution of T cells, T cell subsets and Ia-positive macrophages in lesions of different ages. J Neuroimmunol. 1983; 4(3):201-21. DOI: 10.1016/0165-5728(83)90036-x. View

12.

Faria D, Copray S, Sijbesma J, Willemsen A, Buchpiguel C, Dierckx R . PET imaging of focal demyelination and remyelination in a rat model of multiple sclerosis: comparison of [11C]MeDAS, [11C]CIC and [11C]PIB. Eur J Nucl Med Mol Imaging. 2014; 41(5):995-1003. DOI: 10.1007/s00259-013-2682-6. View

13.

Pietroboni A, Carandini T, Colombi A, Mercurio M, Ghezzi L, Giulietti G . Amyloid PET as a marker of normal-appearing white matter early damage in multiple sclerosis: correlation with CSF β-amyloid levels and brain volumes. Eur J Nucl Med Mol Imaging. 2018; 46(2):280-287. DOI: 10.1007/s00259-018-4182-1. View

14.

van der Weijden C, Biondetti E, Gutmann I, Dijkstra H, McKerchar R, Faria D . Quantitative myelin imaging with MRI and PET: an overview of techniques and their validation status. Brain. 2022; 146(4):1243-1266. PMC: 10115240. DOI: 10.1093/brain/awac436. View

15.

Wu C, Wei J, Tian D, Feng Y, Miller R, Wang Y . Molecular probes for imaging myelinated white matter in CNS. J Med Chem. 2008; 51(21):6682-8. PMC: 2717170. DOI: 10.1021/jm8003637. View

16.

Matias-Guiu J, Cabrera-Martin M, Matias-Guiu J, Oreja-Guevara C, Riola-Parada C, Moreno-Ramos T . Amyloid PET imaging in multiple sclerosis: an (18)F-florbetaben study. BMC Neurol. 2015; 15:243. PMC: 4660647. DOI: 10.1186/s12883-015-0502-2. View

17.

Pytel V, Matias-Guiu J, Matias-Guiu J, Cortes-Martinez A, Montero P, Moreno-Ramos T . Amyloid PET findings in multiple sclerosis are associated with cognitive decline at 18 months. Mult Scler Relat Disord. 2020; 39:101926. DOI: 10.1016/j.msard.2020.101926. View

18.

Faria D, de Vries E, Sijbesma J, Dierckx R, Buchpiguel C, Copray S . PET imaging of demyelination and remyelination in the cuprizone mouse model for multiple sclerosis: a comparison between [11C]CIC and [11C]MeDAS. Neuroimage. 2013; 87:395-402. DOI: 10.1016/j.neuroimage.2013.10.057. View

19.

van der Weijden C, van der Hoorn A, Wang Y, Willemsen A, Dierckx R, Lammertsma A . Investigation of image-derived input functions for non-invasive quantification of myelin density using [C]MeDAS PET. Neuroimage. 2022; 264:119772. DOI: 10.1016/j.neuroimage.2022.119772. View

20.

Ramagopalan S, Dobson R, Meier U, Giovannoni G . Multiple sclerosis: risk factors, prodromes, and potential causal pathways. Lancet Neurol. 2010; 9(7):727-39. DOI: 10.1016/S1474-4422(10)70094-6. View